Work Here?
Overview
Vitalant is a nonprofit organization that collects, tests, processes, and distributes blood and biotherapies to hospitals across the United States. Donors give blood at drives and through other programs; the blood is tested for safety, separated into components, stored, and shipped to hospitals, with additional services like apheresis and specialized laboratory work. It stands out because it runs a nationwide nonprofit network with strong donor recruitment, safety standards, and a robust research program, rather than being a for‑profit or regional blood bank. Its goal is to provide a safe and enough blood supply for patients and support doctors with transfusion expertise while advancing transfusion medicine through research and collaboration.
About Vitalant
Industries
Social Impact
Healthcare
Company Size
1,001-5,000
Company Stage
N/A
Total Funding
N/A
Headquarters
Phoenix, Arizona
Founded
1943
Get referred to Vitalant
See people who can refer or advise you
Simplify's Take
What believers are saying
- June 2026 Pittsburgh expansion opens CGT revenue streams beyond routine transfusion services.
- Vitrafy partnership positions Vitalant Innovation Center as a national testbed for frozen RBC replacement.
- March 2026 whole-blood trauma programs and donor campaigns deepen hospital relationships and repeat donations.
What critics are saying
- Legacy RBC cryopreservation tools expire in 2027, threatening Vitalant’s preservation workflows and stockpiles.
- Vitalant depends on donor participation; 2026 incentive campaigns signal chronic supply volatility.
- San Diego Blood Bank merger must clear regulators mid-2026, risking integration delay and distraction.
What makes Vitalant unique
- Vitalant runs one of America’s largest nonprofit blood and biotherapies networks, spanning 900 hospitals.
- Denver Innovation Center tests technologies; 2026 Vitrafy partnership targets next-generation frozen red cells.
- Pittsburgh added NGS in June 2026, building a hub-and-spoke CGT laboratory platform.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
401(k) Company Match
Tuition Reimbursement
Life Insurance
Disability Insurance
Paid Vacation
Employee Resource Groups
Company News
America's Blood Centers connects with state leaders at the 2026 NCSL Legislative Summit. During the last week of July, America's Blood Centers participated in the National Conference of State Legislatures (NCSL) Legislative Summit in Chicago, Illinois. As the foremost annual gathering of state lawmakers and staff from across the country, the Summit offers a unique opportunity to engage with policymakers from both sides of the aisle. NCSL is a nonpartisan organization that provides legislators with policy research, training, and technical assistance tailored to their needs. ABC's presence at the Summit allowed us to connect directly with legislators and staffers from a wide range of states. Eight ABC member blood centers - Blood Assurance, The Community Blood Center (Appleton), ImpactLife, LifeSouth Community Blood Centers, Mississippi Blood Services, Rock River Valley Blood Center, Versiti, and Vitalant - joined ABC at the booth. Vitalant, Versiti, and The Community Blood Center (Appleton) also partnered with ABC to host the first-ever blood drive held at an NCSL Summit. Over two days, more than 120 people registered to donate, and 112 blood products were collected. Given the summer decline in donations, we are deeply grateful to every NCSL participant who rolled up their sleeves to give. At the booth, we shared insights about the vital role community blood centers play in maintaining a safe and reliable blood supply. A steady stream of attendees stopped by, and we made meaningful connections that will help advance our mission. This engagement complements the ongoing work of our member centers through the ABC Council of States. At the Summit, we laid important groundwork on the Council of States' four priority initiatives: 1. Promoting state policies that support the adoption of prehospital blood use; 2. Supporting state-based opportunities for protected employee blood donation leave; 3. Advancing blood donor education curriculum in schools; and 4. Encouraging state resolutions to designate January as Blood Donor Month. We were pleased to see strong enthusiasm from legislators across all four topics. Our next steps include active collaboration between blood centers and their state policymakers, and we are working with our Council of States members to keep the momentum going. To support these efforts, we invite Council of States members to join our upcoming meetings on September 10 at 2:00 PM ET and November 5 at 2:00 PM ET. With the energy from Chicago still fresh, we're already looking ahead to next year's NCSL Legislative Summit in Atlanta. Members interested in joining the booth can reach out to Susan Leppke at [email protected]. Posted in News Contact.
Gildan CHRO Brooke Ferguson and Vitalant Chief People Officer Manny Ocasio join the mainstage lineup for McLean & Company Signature 2026 in Las Vegas. Jul 27, 2026, 09:46 ET Brooke Ferguson, Chief Human Resources Officer at Gildan, and Manny Ocasio, Chief People Officer at Vitalant, have been announced as mainstage speakers for McLean & Company's flagship annual HR conference, Signature 2026, taking place October 4-6, 2026, at Virgin Hotels Las Vegas. Under the event's 2026 theme, "Human-Centric, Future-Ready," HR leaders in attendance can expect practical insights on leading people through a company-defining transformation, creating greater focus amid competing priorities, and strengthening HR's visibility and impact across the organization. TORONTO, July 27, 2026 /CNW/ - Global HR research and advisory firm McLean & Company has added Brooke Ferguson and Manny Ocasio to the mainstage lineup for Signature 2026, scheduled for October 4-6, 2026, at Virgin Hotels Las Vegas. Their sessions will examine how HR leaders can maintain focus, align stakeholders, and demonstrate value while their organizations navigate transformation, integration, and increasing operational complexity. The conference will convene more than 700 HR leaders for three days of mainstage keynotes, interactive sessions, peer exchanges, CHRO panels, and direct access to McLean & Company analysts and advisors. At Signature 2026, Manny Ocasio, Chief People Officer at Vitalant, will deliver his keynote, "From Intent to Impact: Powering HR Transformation." Drawing on his team's experience adopting objectives and key results, or OKRs, Ocasio will explore how a disciplined approach helped Vitalant's HR function sharpen its priorities, improve organizational visibility, and demonstrate measurable impact during a complex ERP implementation. Rather than presenting OKRs as a standalone solution, Ocasio will share how the team refined its approach through complementary tools and practices that accelerated execution. His session will address how HR leaders can translate strategic intent into clear priorities, connect work to outcomes, and communicate progress in ways that build alignment, momentum, and credibility across the organization. Brooke Ferguson, Chief Human Resources Officer at Gildan, will present "Leading People Through a Company-Defining Transformation." Her keynote will offer an inside look at the people and leadership considerations involved as Gildan works through its acquisition of HanesBrands, which doubled Gildan's size and brought together two cultures and tens of thousands of employees around the world. Ferguson will discuss how HR can prioritize critical workstreams when every issue feels urgent, align leaders while decisions and integration activities continue to evolve, and preserve business momentum during sustained uncertainty. She will also examine the balance between operational integration and intentional culture-building, sharing candid lessons about where HR is having the greatest influence, what has worked, and what has required adjustment along the way. "HR leaders are increasingly at the center of the most consequential changes their organizations are undertaking, but influence depends on their ability to turn intent into coordinated action," says Jennifer Rozon, President of McLean & Company. "Manny Ocasio and Brooke Ferguson bring compelling, real-world perspectives on what that requires. Their sessions will give HR leaders attending Signature 2026 a deeper understanding of how to create focus when priorities compete, maintain alignment as transformation unfolds, and make HR's contribution to enterprise outcomes more visible." Signature 2026 is centered on the theme "Human-Centric, Future-Ready," which reflects how HR teams are helping their organizations navigate rapid technological, structural, and workforce change while keeping people at the center of transformation. Through mainstage presentations, fireside discussions, panels, debates, networking events, peer exchanges, and lightning talks, Signature 2026 will provide HR executives, HR directors, people leaders, and HR team members with practical strategies, research-backed insights, and peer-tested approaches they can apply within their organizations. Additional details about the Signature 2026 agenda, keynote speakers, and networking experiences will be released in the coming months. For more information or to register, visit the official McLean Signature event page. Who Attends Signature? McLean Signature attracts HR executives and HR leaders from a wide range of industries, including technology services, higher education, healthcare, manufacturing, government, and financial services. In recent years, more than 60% of attendees have held senior leadership roles, making Signature a high-impact environment for strategic learning and peer networking. Media interested in connecting with McLean & Company analysts for exclusive, research-backed insights and commentary can contact [email protected]. About Virgin Hotels Las Vegas McLean Signature 2026 will take place at Virgin Hotels Las Vegas, located just minutes from the Las Vegas Strip. Designed with connection and comfort in mind, the venue offers modern event spaces, vibrant social settings, world-class dining, and Virgin's signature approach to hospitality, providing an ideal backdrop for learning, collaboration, and connection. About McLean & Company McLean & Company pairs evidence-based research and immediately applicable tools with deep HR expertise to position organizations to meet today's needs and prepare for the future. The global HR research and advisory firm's member organizations enjoy comprehensive resources, full-service diagnostics, workshops, action plans, and advisory services for all levels of HR professionals, from executive leadership to HR leaders to HR team members, that help shape workplaces where everyone thrives. Media professionals can register for unrestricted access to research across IT, HR, and software, and hundreds of industry analysts through the firm's Media Insiders program. To gain access, contact [email protected]. SOURCE McLean & Company Media Contact: Sufyan Al-Hassan, PR Director, Info-Tech Research Group, [email protected] | +1 (888) 670-8889 x2418
Vitalant expands Pittsburgh lab capabilities to support cell and gene therapy development. Expansion reflects broader effort to scale advanced testing capabilitie across Vitalant's network 30 Jun 2026 Industry news. Vitalant has launched expanded analytical and next-generation sequencing (NGS) testing capabilities at the Vitalant Coagulation Laboratory in Pittsburgh, Pennsylvania, as part of a national cell and gene therapy (CGT) strategy to scale advanced laboratory services across its network and better support patients, healthcare providers and therapy developers. Expansion of Pittsburgh coagulation laboratory. The Vitalant Coagulation Laboratory in Pittsburgh has long supported the research, diagnosis and treatment of blood coagulation disorders. With this latest expansion, the laboratory now incorporates NGS into a coordinated, hub-and-spoke model for CGT, adding advanced testing capabilities that strengthen Vitalant's national biotherapies infrastructure. Through this enhanced role, the Pittsburgh lab contributes to a broader analytical framework that supports donor and starting material testing, in-process monitoring and release testing. These services are essential for transfusion medicine, transplantation and the development of cell and gene therapies. Part of a national CGT and advanced testing strategy. The Pittsburgh expansion is a key milestone in Vitalant's larger strategy to align and scale advanced testing capabilities across its laboratories in Phoenix, San Francisco and Pittsburgh. By coordinating specialized services to support the development, validation and delivery of molecular and cell-based assays, Vitalant is building a connected, scalable platform for biotherapy development. Integrated hub-and-spoke model for laboratory services. The expansion reflects Vitalant's ongoing efforts to consolidate and integrate laboratory services, building on existing capabilities across its national network, including centralized analytics initiatives in Phoenix. This integrated hub-and-spoke approach enables greater standardization, operational efficiency and access to advanced testing, while supporting consistent quality and regulatory alignment. Through this coordinated model, Vitalant addresses a wide range of analytical needs, from donor and starting material testing to in-process monitoring and release testing. This comprehensive testing ecosystem is designed to support both routine clinical care and cutting-edge research in transfusion medicine, transplantation, and cell and gene therapy development. Enhanced NGS and advanced analytics for bleeding disorders and critical care. The addition of NGS testing in Pittsburgh strengthens support for patients with inherited bleeding disorders and those in critical care settings. Advanced genetic testing and immunophenotyping capabilities provide deeper insights into cellular characteristics and function, enabling more precise characterization of disease and treatment response. Together, these services expand Vitalant's ability to deliver high-value, data-driven analytical support across multiple therapeutic areas. By integrating NGS, genetic testing and immunophenotyping into its coagulation and biotherapies portfolio, Vitalant is positioned to meet the evolving needs of clinicians, researchers and therapy developers. Future opportunities in sickle cell disease. Vitalant is also evaluating future opportunities to highlight how these expanded capabilities may support patients with sickle cell disease. Current work in this area is primarily focused on red cell exchange transfusion and related services, with the potential for advanced analytics to further enhance care and research in this patient population. "The Pittsburgh expansion shows more than just the advance of a single laboratory, but how we are leveraging a highly coordinated system to expand these capabilities everywhere, creating a comprehensive testing ecosystem," said Angela Verdoni, Scientific Director, coagulation and MID laboratories, Vitalant. "Our goal is to ensure that advanced diagnostics and analytics are accessible and responsive to the evolving needs of healthcare and research." Want the latest science news straight to your inbox? Become a SelectScience member for free today>>. Frequently asked questions. How does Vitalant's Pittsburgh Coagulation Laboratory expansion support cell and gene therapy development? The expanded Pittsburgh Coagulation Laboratory integrates next-generation sequencing (NGS) into a hub-and-spoke model for cell and gene therapy (CGT). It now supports donor and starting material testing, in-process monitoring and release testing, strengthening Vitalant's national biotherapies infrastructure for transfusion medicine, transplantation and CGT development. What role does Vitalant's integrated hub-and-spoke laboratory model play in advanced testing and biotherapies? Vitalant's integrated hub-and-spoke model connects laboratories in Phoenix, San Francisco and Pittsburgh to align advanced testing capabilities. This coordinated system centralizes analytics, standardizes processes and improves access to molecular and cell-based assays, supporting routine clinical care and cutting-edge research in transfusion medicine, transplantation and cell and gene therapies. How will Vitalant's enhanced NGS and analytics capabilities benefit patients with bleeding disorders and sickle cell disease? Vitalant's addition of NGS, genetic testing and immunophenotyping in Pittsburgh improves characterization of inherited bleeding disorders and critical care cases. These advanced analytics provide deeper insight into cellular function and treatment response. Vitalant is also evaluating how these capabilities can support sickle cell disease care, complementing current work in red cell exchange transfusion and related services.
Employees unite for community Blood drive. Care Synergy affiliates demonstrate their commitment to giving back. On June 25, employees from Care Synergy, The Denver Hospice, Colorado Visiting Nurse Association (CVNA), and Colorado PACE came together for a community blood drive in partnership with Vitalant. While its organizations serve thousands of individuals and families through hospice care, palliative care, senior services, wellness programs, and support services, its commitment to caring for others extends beyond the workplace. Events like today's blood drive provide an opportunity for employees to make an immediate and meaningful impact on the broader community. Blood donations are essential to hospitals and healthcare providers, helping ensure that lifesaving blood products are available for patients experiencing illness, injury, surgery, and other medical needs. By taking time to donate, employees contributed to a critical community resource that supports people throughout the region. The event also reflected the collaborative spirit that unites Care Synergy and its affiliates. Team members from multiple organizations gathered around a shared goal: helping others and strengthening the communities Caresynergynetwork serve. Caresynergynetwork is grateful to Vitalant for partnering with Caresynergynetwork and to every employee who participated in the blood drive. Their generosity and willingness to give of themselves exemplify the compassion, service, and community-minded values that guide its organizations every day. Together, Caresynergynetwork is making a difference - one donation at a time.
Employees unite for community Blood drive. Care Synergy affiliates demonstrate their commitment to giving back. On June 25, employees from Care Synergy, The Denver Hospice, Colorado Visiting Nurse Association (CVNA), and Colorado PACE came together for a community blood drive in partnership with Vitalant. While its organizations serve thousands of individuals and families through hospice care, palliative care, senior services, wellness programs, and support services, its commitment to caring for others extends beyond the workplace. Events like today's blood drive provide an opportunity for employees to make an immediate and meaningful impact on the broader community. Blood donations are essential to hospitals and healthcare providers, helping ensure that lifesaving blood products are available for patients experiencing illness, injury, surgery, and other medical needs. By taking time to donate, employees contributed to a critical community resource that supports people throughout the region. The event also reflected the collaborative spirit that unites Care Synergy and its affiliates. Team members from multiple organizations gathered around a shared goal: helping others and strengthening the communities Denver Hospice serve. Denver Hospice is grateful to Vitalant for partnering with Denver Hospice and to every employee who participated in the blood drive. Their generosity and willingness to give of themselves exemplify the compassion, service, and community-minded values that guide its organizations every day. Together, Denver Hospice is making a difference - one donation at a time.
Vitalant is Hiring for 64 Jobs on Simplify!
Find jobs on Simplify and start your career today
About Vitalant
Industries
Social Impact
Healthcare
Company Size
1,001-5,000
Company Stage
N/A
Total Funding
N/A
Headquarters
Phoenix, Arizona
Founded
1943
Vitalant is Hiring for 64 Jobs on Simplify!
Find jobs on Simplify and start your career today